노벨티노빌리티
1 known investors
Novelty Nobility develops antibody therapeutics using its PREXISE-D platform for fit-for-purpose antibody design and discovery, including antibody-drug conjugates aimed at overcoming drug resistance. The company also pursues treatments related to ophthalmic conditions.